Thomas helps transformative science and tech companies position themselves to maximize their value with investors, public, media and more.

This follows a career in top leadership roles of journalism, as a foreign correspondent for The New York Times and the International Herald Tribune. In marketing and communications, Thomas led major portions of marketing firms Ogilvy & Mather and Edelman and, most recently, he led all of corporate affairs for the $1.2bn Nasdaq IPO of a biotech, GreenLight Biosciences.